Long pages
Jump to navigation
Jump to search
Showing below up to 50 results in range #101 to #150.
View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)
- (hist) CNS leukemia [49,400 bytes]
- (hist) Neuroendocrine tumor [47,524 bytes]
- (hist) Melanoma - null regimens [46,771 bytes]
- (hist) Pembrolizumab (Keytruda) [46,169 bytes]
- (hist) Gastric cancer, HER2-positive [45,088 bytes]
- (hist) COVID-19 coronavirus and cancer [44,604 bytes]
- (hist) B-cell acute lymphoblastic leukemia, pediatric - historical [44,421 bytes]
- (hist) COVID-19 coronavirus medical center experiences [42,776 bytes]
- (hist) Ovarian cancer - null regimens [41,467 bytes]
- (hist) Transformed lymphoma [41,267 bytes]
- (hist) Breast cancer, BRCA-mutated [40,716 bytes]
- (hist) Colon cancer - historical [40,197 bytes]
- (hist) Editing test page [40,118 bytes]
- (hist) Pancreatic NET [39,904 bytes]
- (hist) Antiemesis [38,867 bytes]
- (hist) Ovarian cancer, HRD-positive [38,769 bytes]
- (hist) Polycythemia vera [38,550 bytes]
- (hist) Myelofibrosis [38,540 bytes]
- (hist) Medulloblastoma [38,032 bytes]
- (hist) Primary mediastinal B-cell lymphoma [37,359 bytes]
- (hist) Breast cancer, HER2-positive - historical [37,080 bytes]
- (hist) Medulloblastoma - historical [36,857 bytes]
- (hist) Breast cancer - null regimens [36,695 bytes]
- (hist) Anal cancer [36,358 bytes]
- (hist) Leiomyosarcoma [36,222 bytes]
- (hist) Hairy cell leukemia [36,133 bytes]
- (hist) Prostate cancer - null regimens [35,745 bytes]
- (hist) Colorectal cancer - null regimens [34,824 bytes]
- (hist) Aplastic anemia [33,233 bytes]
- (hist) Colorectal cancer, MSI-H or dMMR [33,141 bytes]
- (hist) Anaplastic large cell lymphoma [32,510 bytes]
- (hist) Hepatocellular carcinoma - null regimens [32,230 bytes]
- (hist) Carcinoma of unknown primary [31,941 bytes]
- (hist) Hepatoblastoma [31,841 bytes]
- (hist) Urothelial carcinoma - historical [31,700 bytes]
- (hist) Osteosarcoma - historical [31,257 bytes]
- (hist) Thyroid cancer, differentiated [30,870 bytes]
- (hist) Ewing sarcoma, pediatric - historical [30,566 bytes]
- (hist) Gastric cancer - null regimens [30,505 bytes]
- (hist) Breast cancer, ER-positive - null regimens [30,188 bytes]
- (hist) Immunotherapy toxicity management [30,081 bytes]
- (hist) Main Page [30,016 bytes]
- (hist) Editorial Board [29,960 bytes]
- (hist) Kaposi sarcoma [29,261 bytes]
- (hist) Multiple myeloma - null regimens [29,117 bytes]
- (hist) Stem cell mobilization regimens [29,100 bytes]
- (hist) Hodgkin lymphoma, nodular lymphocyte-predominant [28,856 bytes]
- (hist) Editorial board transclusions [28,854 bytes]
- (hist) Mantle cell lymphoma - historical [28,273 bytes]
- (hist) Prostate cancer, BRCA-mutated [27,832 bytes]